Life SciencesReview - ResearchInChina

Search by Type

Report Charts News

Search by Company

Code Company name

Category

Home>Review

Remember Me Next Time

Life Sciences

RMB2.99 million funds favorable for the capital structure im
North China Pharmaceutical Co., Ltd.(600812.SH) announced the resumption of trading on Oct 24 since its suspension fr...
Modern Pharmaceutical to set up 277-million-Yuan essential d
October 21-Modern Pharmaceutical (600420.SH) discloses that the company's holding subsidiary company (Modern Hass...
Jinling Pharmaceutical (000919.SZ) reduced investment in sec
During Jan. to Sept. 2011, performance of Jiling Pharmaceutical steadily improved. Its operating revenue reached RMB1...
Topchoice Medical (600763.SH): Growth Accelerates in Q3, wit
In the first three quarters of 2011, Topchoice Medical Investment Co., Inc. (600763.SH) realized operating reve...
Zhifei Biological (300122.SZ): Its Net Income Drops 25.5%in
From Jan. to Sep. in 2011, Chongqing Zhifei Biological Products Co., Ltd attainted operating revenue of RMB 460 milli...
Topchoice (600763.SH): Its Subordinated Ningbo Stomatology H
In H1 2011, Topchoice Medical Investment Co. Inc. (600763.SH) realized operating revenue of RMB 132.542 million, up 2...
KHB (002022.SZ): It increases R&D investment to achieve rese
On June 27 and 29, 2011, KHB (002022.SZ) was in succession granted with ‘Medical Device Registration Certificat...
Grandhope Biotech (300238.SZ): Its Share of Mater Market Eve
Grandhope Biotech’s key product, Normal GEN (Membrane) has broken the monopoly of imports since it was launched...
Walvax Biotechnology (300142.SZ): business shot up in 2011H1
In 2011H1, operating revenue of Walvax Biotechnology reached RMB180 million, up 42.6% YoY; while its net income achie...
Benefiting from biological products, Jinyu Group attained a
From January to June in 2011, the operating revenue of Jinyu Group registered RMB 240 million, down 18.0% YoY, with n...
North China Pharmaceutical Co., Ltd. (600812.SH) received ap
North China Pharmaceutical announced on Sep 15, 2011 that its gene recombinant human albumin had obtained Drug Manufa...
Changshan Biochemical Pharmaceutical’s capacity of low molec
Changshan Biochemical Pharmaceutical (hereafter referred as CSBIO) was listed in Shenzhen Stock Exchange on 19 Aug. 2...
Beijing SL Pharmaceutical invested PnuVax and entered into h
Beijing SL Pharmaceutical announced on 13th Aug, that it will invest RMB130 million to set up joint-venture PnuVax SL...
Concord Medical Services Holdings Announces Participation in
BEIJING, Aug. 23, 2011 /PRNewswire via COMTEX/ -- Concord Medical Services Holdings Limited ("Concord Medical&qu...
Zhejiang Zhenyuan To Raise 530M Yuan From PrivatePlacement
August 22 -- Zhejiang Zhenyuan (000705) filed it will raise 530 million yuan from a private placement of 41.75 millio...

Yisheng Pharmaceutical Intends to Buy 21.58 Million Yuan Sha
Yisheng Pharmaceutical Company (002566.SZ) announced that the company intends to use the over-raised funds of RMB21.5...
Fuan Pharmaceutical to Spend RMB61.2 Million to Purchase 51%
October 17-Fuan Pharmaceutical (300194) plans to issue over-raised funds of RMB61.2 million to purchase 51% stock rig...
TONGHUA DONGBAO PHARMACEUTICAL (600867.SH): short term profi
Operating revenue of Tonghua Dongbao Pharmaceutical reached RMB560 million in Jan. to Sept. 2011, up 21.2% YoY; while...
Ringpu Biology (300119.SZ): It Sees 78.3% Rise in Q1-Q3 Reve
On Oct.25, 2011, Tianjin Ringpu Bio-technology Co., Ltd. (300119.SZ) published its Q1-Q3 Report disclosing that in Ja...
AnkeBio (300009.SZ): Its Long-Acting GH Starts Clinical Tria
On Oct. 11, 2011, Anhui Anke Biotechnology (Group) Co., Ltd. (300009.SZ) announced that its PEG Long-Acting Human Gro...
Hualan Biological (002007.SZ): Second Flu Vaccine Workshop P
On October 13th, 2011, Hualan Biological Engineering Inc. (002007.SZ) annouced that the second flu vaccine workshop a...
Edan Instruments, Inc. (300206.SZ): Net Income of the Compan
In H1 2011, the operating revenue of Edan Instruments, Inc. (300206.SZ) realized RMB 170 million, up 17.2% YoY, and i...
AIER OPHTHALMOLOGY (300015.SZ) invested RMB30 million on two
AIER OPHTHALMOLOGY announced on 27 Aug. 2011, that it would invest two new hospitals in Yongzhou of Hunan province an...
Grandhope Biotech was Listed on GEM Board, raising RMB 278.4
On July 6, 2011, Guangdong Grandhope Biotech Co., Ltd. was listed on GEM board of Shenzhen Stock Exchange, with code ...
Guangzhou Improve Medical Instruments (300030.SZ): blood col
Operating revenue of Guangzhou Improve Medical Instruments Co., Ltd. (300030.SZ) reached RMB98.08 million in 2011H1, ...
Hepalink Pharmaceutical: profit declined in 2011H1, influenc
Operating revenue of Hepalink Pharmaceutical reached RMB1.57 billion in 2011H1, a decline of 13% YoY; meanwhile, its ...
Performance of Shinva Medical was driven by the enhanced pri
Benefitting from the release of new GMP issued by SFDA and the enhanced primary medical facility construction, operat...
Hualan Biological Engineering’s vaccine performance declined
On 16 Aug. 2011, Hualan Biological released its semi-annual report, according to which, its operating revenue reached...
China Kanghui Holdings Announces Participation in Upcoming I
CHANGZHOU, China, Aug. 22, 2011 /PRNewswire-Asia/ -- China Kanghui Holdings (NYSE: KH) ("Kanghui" or the &q...

[ 1 ]